{"id":"W1607289836","doi":"10.3171/2013.1.jns1291","title":"Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma","year":2013,"lang":"en","type":"article","venue":"Journal of neurosurgery","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Glioma; Glioblastoma; Brain tumor; Stereotactic biopsy; Clinical trial; Coagulative necrosis; Nuclear medicine; Surgery; Biopsy; Radiology; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001890828,0.001373659,0.001391302,0.0003398758,0.0003552582,0.001108057,0.0007294484,0.0009629509,0.003251997],"category_scores_gemma":[0.0008455869,0.0003664072,0.0009609276,0.0002610447,0.0007225234,0.0006452301,0.0002340111,0.002155665,0.000801112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001129457,"about_ca_system_score_gemma":0.001269256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001269488,"about_ca_topic_score_gemma":0.004070843,"domain_scores_codex":[0.9996315,0.0001819238,0.00002174903,0.00005239799,0.00004261999,0.00006963806],"domain_scores_gemma":[0.9995564,0.00005922643,0.0001185921,0.00004225676,0.00004082641,0.0001827369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5846427,0.06477103,0.006611737,0.002457992,0.002582738,0.0004151697,0.0006992743,0.004711885,0.07197886,0.0007978762,0.01554481,0.2447859],"study_design_scores_gemma":[0.3861788,0.5819998,0.01373838,0.0001315364,0.0008579462,0.000554639,0.00009197956,0.002082892,0.007407033,0.0004307283,0.006477088,0.00004928258],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9857961,0.006052852,0.000880739,0.0008614939,0.000169842,0.002201364,0.001226477,0.0001556311,0.002655661],"genre_scores_gemma":[0.9829653,0.004245448,0.002151503,0.001255516,0.0001500997,0.002846919,0.002444408,0.00005482149,0.003886005],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003251997,"threshold_uncertainty_score":0.01087904,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06598230483903746,"score_gpt":0.3569493983915693,"score_spread":0.2909670935525319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}